Skip to main content

Table 3 Effects of E. fluctuans on lipid profile and atherogenic index in the study subjects

From: Glucose and lipid lowering effects of Enhydra fluctuans extract in cadmium treated normal and type-2 diabetic model rats

Para-meters Days N-C N-Cd N-P N-PCd DM-P DMP-Cd
Chol (mg/dl) 0 day 75 ± 19 72 ± 18 76 ± 18 73 ± 15 75 ± 15 75 ± 10
21 day 67 ± 8 75 ± 8 68 ± 7 68 ± 15 84 ± 12 73 ± 13
TG (mg/dl) 0 day 58 ± 18 57 ± 15 55 ± 13 62 ± 21 53 ± 5 83 ± 12
21 day 51 ± 8 50 ± 12 48 ± 18 61 ± 18 56 ± 10 56 ± 12
HDL-C (mg/dl) 0 day 65 ± 15 64 ± 16 59 ± 9 65 ± 17 67 ± 14 58 ± 4
21 day 65 ± 11 70 ± 7 64 ± 7 63 ± 15 78 ± 10 68 ± 13
TG/HDL-C ratio 0 day 0.75 (0.49–2.38) 0.84(0.62–1.41) 0.89(0.74–1.24) 0.90(0.59–1.92) 0.83(0.66–0.98) 1.57(1.07–1.64)
21 day 0.74(0.60–1.15) 0.65(0.60–1.12) 0.66(0.48–1.27)* 0.82(0.62–1.89) 0.74(0.47–0.96) 0.81(0.63–1.08)*
  1. Results are expressed as Mean ± SD or Median (range) as appropriate. Statistical analysis within groups was done using paired t-test and WilCoxon rank sum test. SD, Standard deviation; * and ** indicate statistically significant (p < 0.05 and p < 0.01) levels from a paired t-test